juvenile dermatomyositis and outcome measures Archives

Abstract Number: 1370 • ACR/ARHP Annual Meeting 2016
Development and Validation of a Composite Disease Activity Score for Juvenile Dermatomyositis
Silvia Rosina¹, Alessandro Consolaro¹, Pieter van Dijkhuizen¹, Kiran Nistala², Nicola Ruperto¹, Clarissa Pilkington³ and Angelo Ravelli¹, ¹Rheumatology, Giannina Gaslini Institute, Genova, Italy, ²Centre for Rheumatology, University College London, London, United Kingdom, ³Paediatric Rheumatology, Great Ormond Street Hospital NHS Trust, London, United Kingdom
Background/Purpose: JDM is a multisystem vasculopathic disease that primarily affects the skin and muscles. Most tools for assessment of disease activity in JDM are lenghty,…
Abstract Number: 1373 • ACR/ARHP Annual Meeting 2016
Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologists
Janice Tiao^1,2, Rui Feng³, Emily M. Berger⁴, John F. Brandsema⁵, Carrie C. Coughlin⁶, Neelam Khan², Elizabeth A. Kichula⁵, Melissa A. Lerman⁷, Svetlana Lvovich⁸, Patrick J. McMahon⁹, Lisa G. Rider¹⁰, Adam I. Rubin², Lisabeth V. Scalzi¹¹, Douglas M. Smith⁵, Alysha J. Taxter¹², James R. Treat⁹, Ryan P. Williams¹³, Sabrina W. Yum⁵, Joyce Okawa² and Victoria P. Werth^1,2, ¹Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, ²Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, ⁴Hackensack University Medical Center, Hackensack, NJ, ⁵Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁶Division of Dermatology, Washington University School of Medicine, St. Louis, MO, ⁷Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁸St. Christopher's Hospital for Children, Philadelphia, PA, ⁹Division of Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, ¹⁰Environmental Autoimmunity Group, Program of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, ¹¹Department of Rheumatology, Penn State Hershey Children’s Hospital, Hershey, PA, ¹²Pediatrics, Brenner Children's Hospital, Wake Forest Baptist Medical Center, Winston-Salem, NC, ¹³Minneapolis Clinic of Neurology, Maple Grove, MN
Background/Purpose: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool-Binary Method (CAT-BM) have been shown to be reliable and valid outcome…

Abstracts tagged "juvenile dermatomyositis and outcome measures"

Development and Validation of a Composite Disease Activity Score for Juvenile Dermatomyositis

Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologists